Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence

This study evaluated if iodine-125 brachytherapy prophylaxis after radiofrequency ablation (RFA) prolongs time to recurrence (TTR) and overall survival (OS) of patients in high risk of locoregional hepatocellular carcinoma (HCC) recurrence. 116 patients with total tumor necrosis after RFA were divid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Jian-Fei, Ding, Ya-Hui, Chen, Li, Ying, Xi-Hui, Zhang, Deng-Ke, Wu, Fa-Zong, Zhao, Zhong-Wei, Ji, Jian-Song, Zhang, Wang-Gang, Zou, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473839/
https://www.ncbi.nlm.nih.gov/pubmed/28623296
http://dx.doi.org/10.1038/s41598-017-03831-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473839/
https://www.ncbi.nlm.nih.gov/pubmed/28623296
http://dx.doi.org/10.1038/s41598-017-03831-5

Ejemplares similares